STORM Therapeutics develops RNA modifying enzyme inhibitors for the treatment of sarcomas.
stormtherapeutics.comLinkedInCambridge, United KingdomHealthtechFounded 2015
4 sources
Cambridge, UK is a dateline, not a stated headquarters.
2 sources
Not on the page it cites, so not applied: amount
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The release distinguishes the £14 million extension from the £30 million total Series A financing. It names no lead investor.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The release describes this as an additional £4 million extending the £12 million Series A; it does not state a combined financing total. Cambridge, UK is the dateline, not a stated headquarters.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series C [ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $56M | 2026-04-16 | not stated | No recent discussion |
4 sources [ VERIFIED ] read against 1 of 4 sources Cambridge, UK is a dateline, not a stated headquarters. | ||||
STORM Therapeutics develops small-molecule drugs that inhibit RNA-modifying enzymes to reprogram cells and treat cancer and other diseases, with lead drug STC-15 being evaluated in select sarcomas.
Checked against 10 sources today
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $30M | 2022-12-14 | M Ventures, Pfizer Ventures, Taiho Ventures, Cambridge Innovation Capital, Fast Track Initiative (FTI), UTokyo Innovation Platform | No recent discussion |
2 sources [ VERIFIED · CORRECTED ] read against 2 sources
Not on the page it cites, so not applied: amount [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: stormtherapeutics.com, prnewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $17.8M £30M financing total £14 million | 2019-05-20 | not stated | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The release distinguishes the £14 million extension from the £30 million total Series A financing. It names no lead investor. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: stormtherapeutics.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $5.4M £4 million | 2018-01-08 | Taiho Ventures | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
The release describes this as an additional £4 million extending the £12 million Series A; it does not state a combined financing total. Cambridge, UK is the dateline, not a stated headquarters. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: stormtherapeutics.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $16.1M £12 million | 2016-06-28 | not stated | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: stormtherapeutics.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||